Remove Atherosclerosis Remove Hypertension Remove Risk Factors
article thumbnail

No Plaque, No Problem: Tackling Atherosclerosis Prevention

Cardiometabolic Health Congress

While advances in treatment have reduced mortality in some regions, the atherosclerosis prevention remains challenging. This shift results from an epidemiologic transition: as infectious diseases decline, chronic conditions like atherosclerosis dominate.

article thumbnail

Association of blood pressure and left ventricular mass with subclinical coronary atherosclerosis

Open Heart

This study aimed to evaluate the risk factors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovascular disease. Individuals were stratified based on LVMI and the presence of CAC, and intergroup differences in risk factors were analysed.

article thumbnail

Abstract WP56: Dental Flossing associated with reduced White Matter Hyperintensity and Intracranial Atherosclerosis

Stroke Journal

Introduction:Prior studies have shown the association between oral infection, white matter hyperintensity (WMH), a marker of cerebral small vessel disease (CSVD), and asymptomatic intracranial atherosclerosis (ICAS). However, the impact of preventative oral behavior such as dental flossing is unknown. The log WMH volume was higher (9.50.85

article thumbnail

How High Blood Pressure Affects Your Heart and What You Can Do About It

MIBHS

High blood pressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. Hypertension is diagnosed when blood pressure consistently reads 130/80 mm Hg or higher.

article thumbnail

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

DAIC

The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.

Pacemaker 105
article thumbnail

Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease

Hypertension Journal

Hypertension, Ahead of Print. BACKGROUND:Orthostatic hypertension is an emerging risk factor for adverse events. These differences in CVD risk raise important concerns about combining systolic orthostatic increases and standing SBP 140 mm Hg in a consensus definition for orthostatic hypertension.

article thumbnail

Atherosclerosis Updates from the 92nd EAS Congress

Cardiometabolic Health Congress

The EAS 2024 Congress (May 26-29, 2024) has concluded, providing critical insights into atherosclerosis and related vascular disease. This has major potential to refine risk stratification and enhance patient management. Here are some notable highlights: Prof. In contrast, Dr. Michael D.